- Easy Tracking In The Watchlist
Strong day for Context Therapeutics Inc. stock price on Friday rising 6.88% to $0.599
(Updated on Jun 26, 2026)
The Context Therapeutics Inc. stock price gained 6.88% on the last trading day (Friday, 26th Jun 2026), rising from $0.560 to $0.599. During the last trading day the stock fluctuated 8.59% from a day low at $0.568 to a day high of $0.617. The price has fallen in 7 of the last 10 days and is down by -57.85% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 3 million more shares were traded than the day before. In total, 5 million shares were bought and sold for approximately $2.74 million.
The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $0.532 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -41.75% during the next 3 months and, with a 90% probability hold a price between $0.310 and $1.40 at the end of this 3-month period.
CNTX Signals & Forecast
A buy signal was issued from a pivot bottom point on Thursday, June 25, 2026, and so far it has risen 6.88%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Context Therapeutics Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.607 and $1.81. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).
Support, Risk & Stop-loss for Context Therapeutics Inc. stock
Context Therapeutics Inc. finds support from accumulated volume at $0.576 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.0488 between high and low, or 8.59%. For the last week, the stock has had daily average volatility of 13.49%.
Context Therapeutics Inc. is oversold on RSI14 (7). Some stocks may fall long and hard while being oversold on RSI, but stocks that are heavily oversold on RSI often pose good re-bounce chance and played well it can be a buy candidate.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (CNTX) For The Upcoming Trading Day Of Monday 29th
For the upcoming trading day on Monday, 29th we expect Context Therapeutics Inc. to open at $0.595, and during the day (based on 14 day Average True Range), to move between $0.518 and $0.679, which gives a possible trading interval of +/-$0.161 (+/-31.15%) up or down from last closing price. If Context Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 31.15% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $0.600 (0.25%) than the support at $0.576 (3.76%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Context Therapeutics Inc. stock A Buy?
Context Therapeutics Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.
Current score:
-2.777
Sell Candidate
Upgraded
Predicted Fair Opening Price
Predicted fair opening price on June 29, 2026 - $0.595 ( 0.635%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
CNTX Performance
Trading levels for CNTX
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0.644 | 7.52% |
| R2 | 0.625 | 4.40% |
| R1 | 0.613 | 2.48% |
| Price | 0.599 | |
| S1 | 0.576 | -3.75% |
| S2 | 0.565 | -5.67% |
| S3 | 0.546 | -8.79% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0.679 | 13.47% |
| R2 | 0.650 | 8.65% |
| R1 | 0.600 | 0.251% |
| Price | 0.599 | |
| S1 | 0.576 | -3.76% |
| S2 | 0.560 | -6.43% |
| S3 | 0 | - |
FAQ
Click here for our free guide on how to buy Context Therapeutics Inc. Stock.
Buy CNTX